Logo

Twist Bioscience Monkeypox Virus Synthetic DNA Controls

Jul 14, 2022

Twist Bioscience has launched two human monkeypox virus synthetic DNA controls.

Positive controls can be used in development and validation of next-generation sequencing and PCR assays. The Twist controls include both known clades of the virus: the Congo Basin (Central African) clade and the West African clade. Made up of 1.8 Kb of overlapping fragments that tile the genome, the controls cover 80 percent of the full viral genome and are sequence verified using NGS and droplet digital PCR.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.